Robert Cyran moved from the London office to New York, where he covers global technology, pharmaceuticals and special situations. Rob began his career at Forbes magazine, where he assisted in the start-up of the international version of the magazine. Before working at breakingviews he worked as a market researcher and reporter covering the pharmaceutical industry. Robert has a Masters degree in economics from Birmingham University and an undergraduate degree from George Washington University. Follow Rob on Twitter @rob_cyran
- Tel: +1 646 223 6083
- E-mail: firstname.lastname@example.org
Based on the 2007 A&P-Pathmark merger, synergies could be worth more than half the $9.4 bln Cerberus’s Albertsons is paying for its rival U.S. grocer. In theory that leaves room for a higher offer. But competition means cost savings may need to go to shoppers, not investors.
The online merchant thinks owning a payments unit is symbiotic. But activist Carl Icahn says the businesses would be worth more separated. EMC garnered some of the best of both worlds by partially spinning off VMware. The same approach at eBay could defuse the tension.
The Tesla CEO reckons he can kick off a virtuous circle by doubling world lithium-ion battery production. Musk expects that to slash costs by more than 30 pct and add a turbo boost to Tesla’s sales. It may also leave electric pylons looking as outdated as telephone poles.
- PayPal has outgrown eBay's warm embrace
- Bursting U.S. gun bubble begins to take victims
- Icahn's eBay rant also targets Silicon Valley club
- Buffett's folksy ways evoke quainter trading days
- No algorithm makes Facebook-WhatsApp deal compute
- Apollo and TPG try to stack the deck at Caesars
- Actavis makes pharma deals look generic